Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$3.99

Avg closing price
Price range

10 Ken Griffin Pluristem Therapeutics Trades

The first Pluristem Therapeutics trade was made in Q1 2020. Since then Ken Griffin bought shares five more times and sold shares on four occasions. The investor sold all their shares in Q3 2022 and doesn't own any shares in Pluristem Therapeutics anymore.

Avg closing price
Price range
Sold -107 Thousand shares Q3 2022
Avg closing price $1.14
Price range $1.00 - $1.33
Increased shares by 81.5% (+48 Thousand shares) Q2 2022
Avg closing price $1.54
Price range $1.18 - $2.18
Increased shares by 199.0% (+39.2 Thousand shares) Q1 2022
Avg closing price $1.80
Price range $1.42 - $2.14
Sold 66.1% shares (-38.4 Thousand shares) Q4 2021
Avg closing price $2.47
Price range $1.46 - $3.10
Sold 38.1% shares (-35.7 Thousand shares) Q3 2021
Avg closing price $3.20
Price range $2.65 - $3.96
Increased shares by 61.9% (+35.9 Thousand shares) Q2 2021
Avg closing price $4.14
Price range $3.54 - $4.95
Increased shares by 246.2% (+41.2 Thousand shares) Q1 2021
Avg closing price $6.55
Price range $4.48 - $8.49
New holding (+16.7 Thousand shares) Q3 2020
Avg closing price $9.56
Price range $8.40 - $11.48
Sold -48.3 Thousand shares Q2 2020
Avg closing price $8.17
Price range $3.25 - $12.43
New holding (+48.3 Thousand shares) Q1 2020
Avg closing price $3.74
Price range $2.89 - $4.66

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!